Abstract

Early diagnosis of primary systemic vasculitis is important to allow the early commencement of therapy in order to avoid damage and poor outcomes. The heterogeneous nature of vasculitis presents a diagnostic challenge which may hinder early diagnosis. Anti-neutrophilic cytoplasmic antibody testing has been of particular benefit in defining a subgroup of small-vessel vasculitides and facilitating their earlier diagnosis. Suspicion of vasculitis is an important first step to begin a process of investigation to make or refute the diagnosis. No useful diagnostic criteria exist, but classification criteria have been developed to permit a vasculitis patient to be placed in a diagnostic subgroup. The exclusion of vasculitis 'mimics' and secondary causes of vasculitis are components of diagnosis, which otherwise relies on the recognition of a compatible clinical presentation supported by specific laboratory or imaging tests and confirmatory histology. When the diagnosis remains uncertain, observation over time, repeat investigation and a therapeutic trial may improve the probability of the diagnosis or identify an alternative disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.